tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Abnormalities, Multiple D000015 13 associated lipids
Abortion, Spontaneous D000022 12 associated lipids
Acne Vulgaris D000152 35 associated lipids
Adenocarcinoma D000230 166 associated lipids
Adrenal Insufficiency D000309 3 associated lipids
Akinetic Mutism D000405 1 associated lipids
Albuminuria D000419 18 associated lipids
Alopecia D000505 14 associated lipids
Alopecia Areata D000506 6 associated lipids
Alzheimer Disease D000544 76 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Summaries for patients. Multitarget therapy for induction treatment of lupus nephritis. 2015 Ann. Intern. Med. pmid:25383607
Kwon M et al. Bioequivalence of tacrolimus formulations with different dynamic solubility and in-vitro dissolution profiles. 2015 Arch. Pharm. Res. pmid:24627339
Plock JA et al. Adipose- and Bone Marrow-Derived Mesenchymal Stem Cells Prolong Graft Survival in Vascularized Composite Allotransplantation. 2015 Transplantation pmid:26102613
TuÄŸcu M et al. Tacrolimus-Induced Diabetic Ketoacidosis and Effect of Switching to Everolimus: A Case Report. 2015 Transplant. Proc. pmid:26093759
Aktürk S et al. Pregnancy After Kidney Transplantation: Outcomes, Tacrolimus Doses, and Trough Levels. 2015 Transplant. Proc. pmid:26093738
Rahman S et al. Nordihydroguiaretic acid attenuates skin tumorigenesis in Swiss albino mice with the condition of topical co-administration of an immunosuppressant. 2015 Chem. Biol. Interact. pmid:25770929
Yano S et al. Pharmacokinetics for once-daily modified release formulation of tacrolimus hydrate in unrelated hematopoietic stem cell transplantation. 2015 Ann. Hematol. pmid:25325985
Rossetto AM et al. The full electron structure of the FKBP12/FK506 complex. 2015 J. Biomol. Struct. Dyn. pmid:24471694
Santos T et al. New Recipes With Known Ingredients: Combined Therapy of Everolimus and Low-dose Tacrolimus in De Novo Renal Allograft Recipients. 2015 Transplant. Proc. pmid:26036483
Li DW et al. Risk factors for new onset diabetes mellitus after liver transplantation: A meta-analysis. 2015 World J. Gastroenterol. pmid:26034369
Miura M et al. Tacrolimus reduction with everolimus addition for calcineurin inhibitor-induced arteriolopathy in kidney allografts. 2015 Nephrology (Carlton) pmid:26031588
Ma R et al. FK506 ameliorates podocyte injury in type 2 diabetic nephropathy by down-regulating TRPC6 and NFAT expression. 2015 Int J Clin Exp Pathol pmid:26823720
Liu Z et al. Multitarget therapy for induction treatment of lupus nephritis: a randomized trial. 2015 Ann. Intern. Med. pmid:25383558
Kaieda S et al. Successful treatment of macrophage activation syndrome in a patient with dermatomyositis by combination with immunosuppressive therapy and plasmapheresis. 2015 Mod Rheumatol pmid:24252010
Bifano M et al. An open-label investigation into drug-drug interactions between multiple doses of daclatasvir and single-dose cyclosporine or tacrolimus in healthy subjects. 2015 Clin Drug Investig pmid:25896946
Kawaoka T et al. Two patients treated with simeprevir plus pegylated-interferon and ribavirin triple therapy for recurrent hepatitis C after living donor liver transplantation: case report. 2015 Transplant. Proc. pmid:25891736
Kim YT et al. Co-treatment effect of pulsed electromagnetic field (PEMF) with human dental pulp stromal cells and FK506 on the regeneration of crush injured rat sciatic nerve. 2015 Int. J. Neurosci. pmid:25271799
Ichimaru N et al. Risk factors and incidence for lipid abnormalities in kidney transplant patients. 2015 Transplant. Proc. pmid:25891708
Kogiso T et al. Mycophenolate mofetil may induce prolonged severe anemia during pegylated-interferon/ribavirin/simeprevir therapy in liver transplant recipients. 2015 Clin J Gastroenterol pmid:25963122
Bruckmueller H et al. Which Genetic Determinants Should be Considered for Tacrolimus Dose Optimization in Kidney Transplantation? A Combined Analysis of Genes Affecting the CYP3A Locus. 2015 Ther Drug Monit pmid:25271728
Moscovici BK et al. Treatment of Sjögren's syndrome dry eye using 0.03% tacrolimus eye drop: Prospective double-blind randomized study. 2015 Cont Lens Anterior Eye pmid:25956572
Kim D et al. Hydrogen sulfide and hypoxia-induced changes in TASK (K2P3/9) activity and intracellular Ca(2+) concentration in rat carotid body glomus cells. 2015 Respir Physiol Neurobiol pmid:25956223
Tabchi S et al. Successful treatment of Evans syndrome with Tacrolimus. 2015 Invest New Drugs pmid:25209619
Papadopoulos-Köhn A et al. Daily low-dose tacrolimus is a safe and effective immunosuppressive regimen during telaprevir-based triple therapy for hepatitis C virus recurrence after liver transplant. 2015 Transplantation pmid:25208324
Torres-Espín A et al. Immunosuppression of allogenic mesenchymal stem cells transplantation after spinal cord injury improves graft survival and beneficial outcomes. 2015 J. Neurotrauma pmid:25203134
Bae JM et al. Combination therapy with 308-nm excimer laser, topical tacrolimus, and short-term systemic corticosteroids for segmental vitiligo: A retrospective study of 159 patients. 2015 J. Am. Acad. Dermatol. pmid:25956660
Rojas L et al. Effect of CYP3A5*3 on kidney transplant recipients treated with tacrolimus: a systematic review and meta-analysis of observational studies. 2015 Pharmacogenomics J. pmid:25201288
Weisenseel P and Reich K [Inverse psoriasis]. 2015 Hautarzt pmid:25896586
Ennaifer R et al. Nodular hyperplasia of the gastrointestinal tract after liver transplantation: role of immunosuppressive therapy? A case report. 2015 Transplant. Proc. pmid:25891739
Chung YW et al. Transcriptional activation of nuclear-related factor 2 by FK506 in Jurkat T cells. 2015 Transplant. Proc. pmid:25891728
Hur J et al. Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis. 2015 Chem. Res. Toxicol. pmid:25811541
Malvezzi P and Rostaing L The safety of calcineurin inhibitors for kidney-transplant patients. 2015 Expert Opin Drug Saf pmid:26329325
Legendre L et al. Risk of lymphoma in patients with atopic dermatitis and the role of topical treatment: A systematic review and meta-analysis. 2015 J. Am. Acad. Dermatol. pmid:25840730
Manuyakorn W et al. In vitro cytokine changes after pediatric liver transplantation. 2015 Asian Pac. J. Allergy Immunol. pmid:25840634
Pidala J et al. Prolonged sirolimus administration after allogeneic hematopoietic cell transplantation is associated with decreased risk for moderate-severe chronic graft-versus-host disease. 2015 Haematologica pmid:25840599
Tsai MK et al. B cells and immunoglobulin in ABO-incompatible renal transplant patients receiving rituximab and double filtration plasmapheresis. 2015 J. Formos. Med. Assoc. pmid:25839769
Eaton KV et al. Engineering macrophages to control the inflammatory response and angiogenesis. 2015 Exp. Cell Res. pmid:26610863
Rajaganapathy BR et al. Intravesical Liposomal Tacrolimus Protects against Radiation Cystitis Induced by 3-Beam Targeted Bladder Radiation. 2015 J. Urol. pmid:25839382
Furlan SN et al. Transcriptome analysis of GVHD reveals aurora kinase A as a targetable pathway for disease prevention. 2015 Sci Transl Med pmid:26606970
Nagashima T and Minota S Comment on: The efficacy of tacrolimus in patients with interstitial lung diseases complicated with polymyositis or dermatomyositis. 2015 Rheumatology (Oxford) pmid:25832615
Burke MT et al. Expression of Bcl-xL and Mcl-1 in the nonmelanoma skin cancers of renal transplant recipients. 2015 Am. J. Clin. Pathol. pmid:25780003
Nouchi A et al. [Treatment of angiolymphoid hyperplasia with eosinophilia (ALHE) using topical tacrolimus: Two cases]. 2015 Ann Dermatol Venereol pmid:25778634
Diaz-Siso JR et al. Initial experience of dual maintenance immunosuppression with steroid withdrawal in vascular composite tissue allotransplantation. 2015 Am. J. Transplant. pmid:25777324
Fujibayashi T et al. Comparison of efficacy and safety of tacrolimus and methotrexate in combination with abatacept in patients with rheumatoid arthritis; a retrospective observational study in the TBC Registry. 2015 Mod Rheumatol pmid:25775147
Lehman N et al. Left subconjunctival hemorrhage · renal dysfunction · international normalized ratio of 4.5 · Dx? 2015 J Fam Pract pmid:26551480
Boloori A et al. Characterization of Remitting and Relapsing Hyperglycemia in Post-Renal-Transplant Recipients. 2015 PLoS ONE pmid:26551468
Lightman S et al. Pegylated interferon-α-2b reduces corticosteroid requirement in patients with Behçet's disease with upregulation of circulating regulatory T cells and reduction of Th17. 2015 Ann. Rheum. Dis. pmid:25269831
Mahajan R et al. Co-localization of agminated congenital melanocytic nevi with vitiligo vulgaris: an unusual presentation. 2015 Int. J. Dermatol. pmid:25039486
Qasim W et al. Reply to: "To target or not to target viral antigens in HBV related HCC?". 2015 J. Hepatol. pmid:25711420
TruneÄŒka P et al. Renal Function in De Novo Liver Transplant Recipients Receiving Different Prolonged-Release Tacrolimus Regimens-The DIAMOND Study. 2015 Am. J. Transplant. pmid:25707487
Adam R et al. Improved survival in liver transplant recipients receiving prolonged-release tacrolimus in the European Liver Transplant Registry. 2015 Am. J. Transplant. pmid:25703527
Yokoyama Y et al. Corticosteroid-sparing effect of tacrolimus in the initial treatment of dermatomyositis and polymyositis. 2015 Mod Rheumatol pmid:25775144
Asrani SK and O'Leary JG Can one pill a day keep rejection away? 2015 Am. J. Transplant. pmid:25703394
Kawano N et al. Successful Secondary Umbilical Cord Blood Transplantation for Graft Failure in Acute Myelogenous Leukemia, Treated with Modified One-Day Conditioning Regimen, and Graft-Versus-Host Disease Prophylaxis Consisting of Mycophenolate and Tacrolimus. 2015 J Clin Exp Hematop pmid:26490521
Li ZQ et al. Efficacy and safety of tacrolimus vs. cyclophosphamide for idiopathic membranous nephropathy: A meta-analysis of Chinese adults. 2015 J. Huazhong Univ. Sci. Technol. Med. Sci. pmid:26489612
Chen QQ et al. Kaposi's Varicelliform Eruption During Long-term Treatment of Rosacea with 0.03% Tacrolimus Ointment. 2015 Chin. Med. J. pmid:26481759
Badri P et al. Pharmacokinetics and dose recommendations for cyclosporine and tacrolimus when coadministered with ABT-450, ombitasvir, and dasabuvir. 2015 Am. J. Transplant. pmid:25708713
Peksa GD et al. Dosing algorithm for concomitant administration of sirolimus, tacrolimus, and an azole after allogeneic hematopoietic stem cell transplantation. 2015 J Oncol Pharm Pract pmid:24938293
Cen J et al. The new immunosuppressant, isogarcinol, binds directly to its target enzyme calcineurin, unlike cyclosporin A and tacrolimus. 2015 Biochimie pmid:25701551
Park JH et al. Comparative study of tacrolimus and bevacizumab on corneal neovascularization in rabbits. 2015 Cornea pmid:25651492
Shengyou Y et al. Influence of tacrolimus on podocyte injury inducted by angiotensin II. 2015 J Renin Angiotensin Aldosterone Syst pmid:25650384
Carenco C et al. Tacrolimus and the risk of solid cancers after liver transplant: a dose effect relationship. 2015 Am. J. Transplant. pmid:25648361
Mizokami D et al. Tacrolimus prevents laryngotracheal stenosis in an acute-injury rat model. 2015 Laryngoscope pmid:25647147
Coelho R et al. Nodular Regenerative Hyperplasia after Liver Transplantation Complicated with Inferior Vena Cava Stenosis: a Clue for Etiopathogenesis? 2015 J Gastrointestin Liver Dis pmid:26405712
Romanowski M et al. Interleukin-17 gene polymorphisms in patients with post-transplant diabetes mellitus. 2015 Eur Rev Med Pharmacol Sci pmid:26400516
Rodríguez-Perálvarez M et al. Everolimus is safe within the first month after liver transplantation. 2015 Transpl. Immunol. pmid:26392195
Sahin G et al. Association between endothelial and platelet function markers and adiponectin in renal transplanted recipients on cyclosporine and tacrolimus immunosuppression based therapy. 2015 Nephrology (Carlton) pmid:25650527
Sato M et al. Multifocal Fibrosclerosis with Hypertrophic Pachymeningitis and a Soft Tissue Mass around the Thoracic Vertebral Bodies: A Case Report with Review of the Literature. 2015 Intern. Med. pmid:26328659
Pérez-López I et al. Koebner phenomenon in a patient with lichen sclerosus following a jellyfish sting: an exceptional morphology. 2015 Actas Dermosifiliogr pmid:25597413
Niioka T et al. Capability of utilizing CYP3A5 polymorphisms to predict therapeutic dosage of tacrolimus at early stage post-renal transplantation. 2015 Int J Mol Sci pmid:25594874
Chittock J et al. Comparing the Effect of a Twice-weekly Tacrolimus and Betamethasone Valerate Dose on the Subclinical Epidermal Barrier Defect in Atopic Dermatitis. 2015 Acta Derm. Venereol. pmid:25594610
Ling Q et al. Donor PPARα Gene Polymorphisms Influence the Susceptibility to Glucose and Lipid Disorders in Liver Transplant Recipients: A Strobe-Compliant Observational Study. 2015 Medicine (Baltimore) pmid:26334901
Koch M et al. De novo mTOR inhibitor-based immunosuppression in ABO-incompatible kidney transplantation. 2015 Clin Transplant pmid:26333844
Ge Y et al. The efficacy of tacrolimus in patients with refractory dermatomyositis/polymyositis: a systematic review. 2015 Clin. Rheumatol. pmid:26328518
Graham F et al. Tacrolimus use in renal and cardiac pediatric transplantation: no increased risk of food allergies. 2015 Ann. Allergy Asthma Immunol. pmid:26094803
Velioglu A et al. Association of BK Virus Titers With Lymphocyte Count in Renal Transplant Patients. 2015 Transplant. Proc. pmid:26093733
Demir T et al. Cancer Screening of Renal Transplant Patients Undergoing Long-Term Immunosuppressive Therapy. 2015 Transplant. Proc. pmid:26093731
Park J et al. Iron overload triggers mitochondrial fragmentation via calcineurin-sensitive signals in HT-22 hippocampal neuron cells. 2015 Toxicology pmid:26318285
Shi RZ et al. Rapid measurement of tacrolimus in whole blood by paper spray-tandem mass spectrometry (PS-MS/MS). 2015 Clin. Chim. Acta pmid:25540885
Yang F et al. A clinicopathological study of renal biopsies from 288 elderly patients: analysis based on 4,185 cases. 2015 Int Urol Nephrol pmid:25539617
Webb NJ et al. Corticosteroid-free Kidney Transplantation Improves Growth: 2-Year Follow-up of the TWIST Randomized Controlled Trial. 2015 Transplantation pmid:25539467
Schaap MM et al. A novel toxicogenomics-based approach to categorize (non-)genotoxic carcinogens. 2015 Arch. Toxicol. pmid:25270620
Coilly A et al. Once-daily prolonged release tacrolimus in liver transplantation: Experts' literature review and recommendations. 2015 Liver Transpl. pmid:26264233
Yoo MC et al. Steroid-free Liver Transplantation Using Rabbit Antithymocyte Globulin Induction in 500 Consecutive Patients. 2015 Transplantation pmid:25539464
Boluda ER Pediatric small bowel transplantation. 2015 Curr Opin Organ Transplant pmid:26262456
Offer K et al. Efficacy of tacrolimus/mycophenolate mofetil as acute graft-versus-host disease prophylaxis and the impact of subtherapeutic tacrolimus levels in children after matched sibling donor allogeneic hematopoietic cell transplantation. 2015 Biol. Blood Marrow Transplant. pmid:25536217
Seeling W et al. Knowledge-based immunosuppressive therapy for kidney transplant patients--from theoretical model to clinical integration. 2015 Stud Health Technol Inform pmid:26262418
Wardhana EA and Datau A patient with plaque type morphea mimicking systemic lupus erythematosus. 2015 Acta Med Indones pmid:26260557
Kim SH et al. Conversion of twice-daily to once-daily tacrolimus is safe in stable adult living donor liver transplant recipients. 2015 HBPD INT pmid:26256081
Clift DE et al. Effects of embryonic cyclosporine exposures on brain development and behavior. 2015 Behav. Brain Res. pmid:25591474
van Boekel GA et al. Delayed trough level measurement with the use of prolonged-release tacrolimus. 2015 Transpl. Int. pmid:25474192
Gallagher HM et al. Erratic tacrolimus exposure, assessed using the standard deviation of trough blood levels, predicts chronic lung allograft dysfunction and survival. 2015 J. Heart Lung Transplant. pmid:26186804
Li Y et al. Differential regulation of Tregs and Th17/Th1 cells by a sirolimus-based regimen might be dependent on STAT-signaling in renal transplant recipients. 2015 Int. Immunopharmacol. pmid:26186486
Togashi M et al. Effect of CYP3A5 and ABCB1 polymorphisms on the interaction between tacrolimus and itraconazole in patients with connective tissue disease. 2015 Eur. J. Clin. Pharmacol. pmid:26184414
Toole B et al. Evaluation of the New Cyclosporine and Tacrolimus Automated Electrochemiluminescence Immunoassays under Field Conditions. 2015 Clin. Lab. pmid:26554251
Shen T et al. Reversible sinusoidal obstruction syndrome associated with tacrolimus following liver transplantation. 2015 World J. Gastroenterol. pmid:26034381
Spiekerkoetter E et al. Low-Dose FK506 (Tacrolimus) in End-Stage Pulmonary Arterial Hypertension. 2015 Am. J. Respir. Crit. Care Med. pmid:26177174
Inamoto Y et al. Tacrolimus versus Cyclosporine after Hematopoietic Cell Transplantation for Acquired Aplastic Anemia. 2015 Biol. Blood Marrow Transplant. pmid:26033280
Regelmann MO et al. New-onset diabetes mellitus after pediatric liver transplantation. 2015 Pediatr Transplant pmid:26032592
Cilião HL et al. Cytotoxic and genotoxic effects of high concentrations of the immunosuppressive drugs cyclosporine and tacrolimus in MRC-5 cells. 2015 Exp. Toxicol. Pathol. pmid:25541063